La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Getty Images Holdings a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Getty Images Holdings..

Getty Images Holdings (NYSE:GETY) Azioni, Catena delle Opzioni

GETTY IMAGES HOLDINGS INC

Getty Images Holdings

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GETY

SGMO

STNE

Analisi e previsioni: ecco i titoli che potrebbero superare le aspettative degli analisti, generando guadagni interessanti.

Il martedì di Wall Street: 5 azioni pronte a sorprendere il mercato

CWCO

SAIC

Mercati in fermento: quali opportunità si celano dietro le fluttuazioni di inizio settimana? Ecco 5 nomi da tenere d&#39;occhio.

SAIC, Getty Images e altri 3 titoli pronti a sorprenderti oggi

Long Ideas

FUBO

Un&#39;analisi dei titoli di mercato che mostrano segnali di crescita imminente, che rappresentano un&#39;opportunità interessante per investire.

Queste 3 azioni tecnologiche potrebbero esplodere questo trimestre

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings Inc

Morgan Stanley analyst Terence Flynn maintains Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) with a Equal-Weight and lowers the price target from $99 to $98.

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Merck & Co, Lowers Price Target to $98

Barclays analyst Brandon Oglenski maintains Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) with a Equal-Weight and raises the price target from $101 to $106.

Barclays Maintains Equal-Weight on Canadian National Railway, Raises Price Target to $106

WIIM

USAR

Shares of rare earth companies are trading higher in sympathy with MP, which entered into a  partnership with the U.S. Department of Defense.

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has outperformed the market over the past 20 years by 4.64% on an annualized basis producing an average annual return of 13.11%. Currently, Accenture has a market capitalization of $181.44 billion. 
Buying $1000 In ACN: If an investor had bought $1000 of ACN stock 20 years ago, it would be worth $12,126.80 today based on a price of $291.30 for ACN at the time of writing.
<h3>Accenture's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752164132_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Accenture 20 Years Ago Would Be Worth This Much Today

Rumors

Watching Vertiv; Traders Circulate Analyst Comments Saying Vertiv Is A Key Partner In Building Specific Solutions For Cloud Customers And Is Providing Some Of The Underlying Components For Amazon's Web Services

Apple Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) massive $60+ billion cash pile is once again <a href="https://www.benzinga.com/quote/AAPL/news">in the spotlight</a> &#8211; and with rivals <a href="https://www.benzinga.com/topic/artificial-intelligence">racing ahead in AI</a>, investors are wondering: is it finally time for Apple to make a bold move?
The discussion heated up this week after Apple confirmed that <a href="https://www.benzinga.com/markets/tech/25/07/46311533/jeff-williams-once-tipped-as-tim-cooks-successor-to-retire-from-apple">COO Jeff Williams will retire in 2025</a>, marking a rare leadership shake-up at the famously stable company. While some see it as a routine transition, others say it&#8217;s the opening Apple needs to shift its approach &#8211; particularly on artificial intelligence.
<h2 class="wp-block-heading">AI Spending Gap: Apple Can Afford to Catch Up Fast</h2>
While Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google have made bold AI acquisitions or launched internal platforms (OpenAI partnerships, Gemini, LLaMA, etc.), Apple has largely sat on the sidelines &#8211; despite having one of the biggest acquisition budgets in the game.
<ul class="wp-block-list">
<li>Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46301582/metas-ai-empire-grows-fueled-by-openai-deepmind-apple-defectors">Meta&#8217;s AI Empire Grows — Fueled By OpenAI, DeepMind, Apple Defectors</a></li>
</ul>
While analysts speculate about Apple's next move following the COO exit, the raw numbers suggest it could reshape the AI landscape practically overnight—if it chose to.
Wedbush analyst Dan Ives has pointed out potential AI targets like Perplexity, but others believe Apple should think even bigger. Two names at the top of that list? Datadog Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>), valued at around $48 billion; and Tempus AI Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), valued at approximately $10.4 billion.
Apple's cash reserve &#8211; about $60 billion &#8211; is more than just a cushion for rainy days. It's a strategic asset that dwarfs the entire market capitalizations of some of the rising tech players. Stripping away real-world constraints like deal feasibility, regulatory approval, or strategic fit, Apple's $60 billion cash reserve is large enough—at least on paper—to outright acquire both Datadog and Tempus AI.
In short: if Apple wanted to, and if no constraining rules applied, it has enough cash to scoop up both companies and still have money left over.
<h2 class="wp-block-heading">Leadership Change Could Signal Strategy Shift</h2>
The decentralization of Jeff Williams' role across hardware and operations leaders could loosen Apple's famously tight structure &#8211; and perhaps invite more aggressive bets. The market responded mildly, with shares up 0.5%, but the potential is anything but mild.
If Apple really wants to make noise in AI, it's got the ammo. Now investors are waiting to see if it pulls the trigger.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46342321/nvidia-microsoft-apple-smash-10-trillion-is-this-peak-tech">Nvidia, Microsoft, Apple Smash $10 Trillion—Is This Peak Tech?</a></li>
</ul>
Photo: Shutterstock

Tech

AAPL

DDOG

GOOG

GOOGL

MSFT

Apple Acquisition Buzz: Its $60 Billion War Chest Is Enough To Buy Datadog And Tempus

Morgan Stanley analyst Terence Flynn maintains Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) with a Equal-Weight and raises the price target from $169 to $171.

Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $171

Barclays analyst Benjamin Budish maintains Blue Owl Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) with a Overweight and raises the price target from $21 to $23.

Barclays Maintains Overweight on Blue Owl Capital, Raises Price Target to $23

Morgan Stanley analyst Terence Flynn maintains Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) with a Underweight and lowers the price target from $36 to $34.

Morgan Stanley Maintains Underweight on Bristol-Myers Squibb, Lowers Price Target to $34

Barclays analyst Benjamin Budish maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Equal-Weight and raises the price target from $136 to $168.

Barclays Maintains Equal-Weight on Blackstone, Raises Price Target to $168

Morgan Stanley analyst Matthew Harrison maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Overweight and lowers the price target from $755 to $754.

REGN

Morgan Stanley Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $754

Barclays analyst Benjamin Budish maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $990 to $1220.

Barclays Maintains Overweight on BlackRock, Raises Price Target to $1220

Morgan Stanley analyst Matthew Harrison maintains Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) with a Overweight and raises the price target from $80 to $81.

LEGN

Morgan Stanley Maintains Overweight on Legend Biotech, Raises Price Target to $81

Barclays analyst Nicholas Campanella maintains Atmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) with a Equal-Weight and lowers the price target from $156 to $153.

Barclays Maintains Equal-Weight on Atmos Energy, Lowers Price Target to $153

XRP's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has broken above $2.39 for the first time since May 23, buoyed by growing whale accumulation and bullish momentum around Ripple's ecosystem. 
Market watchers now see signs of <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">an imminent breakout.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
<td>Market Cap</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.44</td>
<td>&nbsp;$144.4 billion</td>
<td>+7.8%</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$111,368.12</td>
<td>&nbsp;$2.2 trillion</td>
<td>+1.6%&nbsp;</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,771.92</td>
<td>&nbsp;$335.1 billion</td>
<td>+7.4%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Cryptoinsightuk <a href="https://x.com/Cryptoinsightuk/status/1943233384819425509">noted</a> that XRP has cleared a key resistance level and is now holding it as hourly support. 
While yesterday's close hinted at bullish continuation, he says a strong close today would confirm a full-blown rally. Similar breakouts in the past have led to explosive moves, signaling what he calls potential "fireworks ahead."
Oscar Ramos, <a href="https://x.com/thecryptobasic/status/1943298136878772542">quoted </a>by Crypto Basic, is urging investors to go &#8220;all-in&#8221; on XRP, calling it a &#8220;must-have&#8221; in bullish portfolios. With Bitcoin hitting new highs at $112,000, altcoins like XRP are following with renewed strength. Ripple's progress with its RLUSD stablecoin and utility expansion is helping drive the sentiment shift.
Statistics: Santiment <a href="https://x.com/santimentfeed/status/1943017401009713342">data</a> shows XRP has reached a 7-week high, surpassing $2.39 for the first time since May 23. 
Whale activity is increasing, with 2,742 wallets now holding at least 1 million XRP, just one short of the all-time high. These large holders now control 47.32 billion XRP, signaling strong confidence in the asset's future.
Coinglass data shows XRP open interest increased 3.9% in a single day while derivatives trading volume expanded by 20.3%. 
Short liquidations of $7.97 million in the past 24 hours, continue to rise for the second consecutive day, implying traders forced to close their positions in the wake of XRP's rally.
Community News: Ripple <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46323539/xrp-boosted-4-by-ripples-stablecoin-partnership-with-bny-mellon">announced</a> that BNY, America's oldest running bank, will act as primary custodian for reserves backing its RLUSD stablecoin. The move aims to accelerate institutional trust and adoption.
Ripple is also actively pursuing a national bank charter and Federal Reserve master account to further legitimize RLUSD, which now <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46318111/xrp-eyes-2-40-as-ripples-rlusd-stablecoin-smashes-500m-market-cap">boasts </a>a more than $500 million market cap, making it the eighth-largest stablecoin after surpassing TrueUSD.
CEO Brad Garlinghouse reiterated that XRP's regulatory clarity is now well established, calling this a green light for broader adoption and use.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46327959/xrp-spikes-3-is-a-breakout-imminent">XRP Spikes 3%: Is A Breakout Imminent?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Breaks Above $2.40 For First Time Since May: How High Can It Go?

Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Overweight and raises the price target from $132 to $133.

BNTX

Morgan Stanley Maintains Overweight on BioNTech, Raises Price Target to $133

Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Overweight and raises the price target from $1133 to $1135.

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1135

Barclays analyst Benjamin Budish maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $182 to $200.

ARES

Barclays Maintains Overweight on Ares Management, Raises Price Target to $200

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Equal-Weight and lowers the price target from $348 to $328.

UTHR

Morgan Stanley Maintains Equal-Weight on United Therapeutics, Lowers Price Target to $328

Morgan Stanley analyst Betsy Graseck maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Overweight and raises the price target from $39 to $47.

ALLY

Morgan Stanley Maintains Overweight on Ally Financial, Raises Price Target to $47

Press Releases

Getty Images to Release First Quarter 2025 Financial Results on May 12, 2025

Getty Images and Ancestry Partner to Digitally Preserve Historic Archives of HBCUs

Legal

Investor Alert: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors in Getty Images, Driven Brands Holdings, Hasbro, and Otter Tail Corporation

Contracts

Getty Images Selected as Official Photographer of 2025 Met Gala

Getty Images Awards $20,000 to Global Storytellers Reshaping Disability Representation

SHUTTERSTOCK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shutterstock, Inc. - SSTK

Getty Images Reports First Quarter 2025 Results

Getty Images Announced as Official Photographer of the 2025 Tribeca Festival

Shutterstock Receives Stockholder Approval for Proposed Merger with Getty Images

New Getty Images Report Finds Consumers Still Care About Sustainability and Expect Businesses to Lead

DRVN

OTTR

SSTK

Angi

The Arena Group Holdings, Inc. Common Stock

Arena Group Holdings

Bumble

Cars.com

EverQuote

FuboTV

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

QuinStreet

Shutterstock

So-Young International Inc. - American Depository Shares

So-Young Intl

Taboola.com

Teads Holding

Tripadvisor

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Ziff Davis

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

Getty Images Holdings

Getty Images Holdings (GETY) Opzioni

Getty Images Holdings (NYSE:GETY) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO